We conducted a meta-analysis of genome-wide association studies of systolic (SBP) and diastolic (DBP) blood pressure in 19,608 subjects of east Asian ancestry from the AGEN-BP consortium followed up with de novo genotyping (n = 10,518) and further replication (n = 20,247) in east Asian samples. We identified genome-wide significant (P < 5 × 10 −8 ) associations with SBP or DBP, which included variants at four new loci (ST7L-CAPZA1, FIGN-GRB14, ENPEP and NPR3) and a newly discovered variant near TBX3. Among the five newly discovered variants, we obtained significant replication in the independent samples for all of these loci except NPR3. We also confirmed seven loci previously identified in populations of European descent. Moreover, at 12q24.13 near ALDH2, we observed strong association signals (P = 7.9 × 10 −31 and P = 1.3 × 10 −35 for SBP and DBP, respectively) with ethnic specificity. These findings provide new insights into blood pressure regulation and potential targets for intervention.
A r t i c l e s
Hypertension is a leading risk factor of cardiovascular disease and premature death globally [1] [2] [3] [4] . It is especially common in Asian populations, contributing to a high incidence of and mortality from stroke 5, 6 . Genetic and environmental factors and their interaction determine an individual's risk for hypertension. Efforts to elucidate the genetic determinants of hypertension, or elevated blood pressure levels 7, 8 , yielded little success until 2009 when two large-scale meta-analyses of genome-wide association studies (GWAS) from the Global Blood Pressure Genetics (Global BPgen) and Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) consortia identified a total of 13 independent loci significantly associated with blood pressure variation 9, 10 . Although the results from the two consortia represented an important advance in hypertension research 11 , these studies were conducted almost exclusively in populations of European descent. Studies in non-European populations will allow us to assess the relevance of these findings to other ethnic groups and potentially discover new variants. The latter is important because some variants may be more common in specific ethnic groups, thereby providing greater power, or the effects of genetic variants on blood pressure may be larger in specific ethnic groups.
The Asian Genetic Epidemiology Network Blood Pressure (AGEN-BP) working group was established to facilitate the identification of genetic variants influencing blood pressure among populations of east Asian ancestry. AGEN-BP includes 19,608 east Asian participants from eight population-and family-based GWAS with standardized blood pressure measurements. Here we report the findings from our three-stage study that included a meta-analysis of blood pressure GWAS from AGEN-BP (stage 1; n = 19,608), de novo genotyping of top loci in additional individuals (stage 2; n = 10,518) and replication of findings in independent east Asian samples (stage 3; n = 20,247) ( Supplementary Fig. 1 ).
RESULTS

Meta-analysis and follow up of new association signals
The stage 1 meta-analysis included 19,608 individuals from eight GWAS in east Asian populations ( Table 1 and Supplementary  Table 1 ). The -log 10 P values by chromosome location for SBP and DBP are shown in Figure 1a and b, respectively. Quantilequantile plots for SBP and DBP are presented in Supplementary  Figure 2 . The overall inflation after meta-analysis was modest (λ GC = 1.03 for SBP and λ GC = 1.02 for DBP). The meta-analysis Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians A r t i c l e s identified two independent association signals reaching genomewide significance (defined as P < 5 × 10 −8 ). These included one locus (ATP2B1) known to harbor variants associated with blood pressure and one newly discovered locus (FIGN-GRB14). Eleven additional variants that have not been previously implicated in the pathogenesis of hypertension were associated with SBP and/or DBP at a significance level of P < 1 × 10 −5 (Supplementary Table 2) .
To increase statistical power and strengthen support for the stage 1 findings, we undertook stage 2 follow up de novo genotyping for 13 SNPs in an additional 10,518 Japanese individuals. These included 12 SNPs that showed associations with P < 1 × 10 −5 and one additional SNP with P < 1 × 10 −3 that was close to a biological candidate gene (NPR3) 12 . In the joint analysis of stages 1 and 2, one additional SNP (rs11066280 at the RPL6-PTPN11 locus) reached genome-wide significance. We carried this SNP and five additional SNPs attaining borderline significance (defined as P < 5 × 10 −6 ) in our joint analysis of stages 1 and 2 forward to a stage 3 replication study involving 20,247 individuals. All six SNPs showed some evidence of replication in the stage 3 study, although the SBP association for rs1173766 (P = 0.016) did not reach a significance level after adjustment for multiple testing (P = 0.05/6 ≈ 0.008). All six SNPs reached genome-wide significance in the joint analysis of stages 1, 2 and 3 ( Table 2 and Fig. 2) . Moreover, two additional variants (rs880315 at the CASZ1 locus and rs155524 at the ITGA9 locus) had previously been genotyped in our stage 2 and stage 3 samples 13 . When combined with data from stage 1, we found that rs880315 at CASZ1 showed an association with DBP that reached genome-wide significance as previously reported 13 .
Finally, on 12q24.21 near TBX3, we detected an association between blood pressure and rs35444, which is approximately 200 kb away from the reported lead SNP (rs2384550) identified in populations of European descent and its proxies. Because there is no linkage disequilibrium (LD) A r t i c l e s between the two clusters of SNPs on 12q24.21 in either ethnic group (r 2 = 0.000, D´ = 0.018 in HapMap JPT+CHB; r 2 = 0.003, D´ = 0.063 in HapMap CEU between rs35444 and rs2384550), we consider the association at rs35444 independent and new, presumably indicating the presence of allelic heterogeneity between the ethnic groups.
East Asian-specific associations at 12q24. 13 We detected one of the most prominent blood pressure associations at 12q24.13 (rs11066280, effect allele frequency = 0.75, per-allele effect = 1.56 mm Hg for SBP (P = 7.9 × 10 −31 ) and 1.01 mm Hg for DBP (P = 1.3 × 10 −35 ) in the joint analysis of stages 1, 2 and 3; Table 2 ). This association is likely driven by a known functional variant rs671 at ALDH2, which is common in east Asians and has been reported to associate with hypertension principally through modification of alcohol consumption [14] [15] [16] [17] . Among the proxy SNPs in the surrounding region, we found strong LD (r 2 = 0.87) between rs11066280 and rs671 (Supplementary Table 3 ). In addition, both SNPs showed an association with blood pressure in the β is the effect size on blood pressure in mm Hg per coded allele based on an additive genetic model. Shown is the top SNP for each independent locus significantly (P < 5 × 10 -8 ) associated with systolic and/or diastolic blood pressure on joint analysis in up to 50,373 individuals of east Asian ancestry. Detailed results for the individual loci separately by study are presented in supplementary table 2. For the Fukuoka study and KING study in stage 3, we used genotype data of rs12413409 for rs11191548 (r 2 = 0.98) at CNNM2-NT5C2 and a proxy (rs2681472, r 2 = 0.98) for rs17249754 at ATP2B1; the linkage disequilibrium coefficient (r 2 ) was estimated based on 5,331 Japanese samples (CAGE-Amagasaki study). Four loci (CASZ1, FGF5, CNNM2-NT5C2 and ATP2B1) in the table were previously reported to associate with blood pressure in a Japanese replication study 13 , the samples of which constitute the participants in the present GWAS meta-analysis. Imputed data were unavailable for rs16998073 at FGF5, and only the results for the follow-up analysis are shown in the table.
a Measurements in mm Hg. b Lead SNPs at the loci previously identified in Europeans were directly genotyped for follow-up in part of stage 2 and stage 3 samples. Chr., chromosome.
A r t i c l e s CAGE-Amagasaki, Fukuoka and KING Studies (n = 21,875; Supplementary Table 4) . When both SNPs were simultaneously included in the regression model, statistical significance remained for rs671 (P = 0.018 for SBP and P = 8.9 × 10 −4 for DBP) but not for rs11066280 (P > 0.05). However, conclusive evidence for the primary source of association at 12q24.13 remains to be provided. The two SNPs are close to SH2B3 (Fig. 3a) , one of the blood pressure loci identified in populations of European descent 9, 10 . The SNP at 12q24.13 associated with blood pressure in populations of European descent (rs3184504 at the SH2B3 locus) is not polymorphic in east Asians, and the SNP associated with blood pressure in our study (rs671 at the ALDH2 locus) is not polymorphic in Europeans. Also, we found modest signatures of recent selection, which was supported by several types of population genetic evidence, for example, reduction of haplotype diversity in east Asians, and suggestive evidence of a selective sweep in east Asians at 110.7-111.4 Mb (empirical P < 0.01) by two haplotype-based tests: iHS scores 18 and XP-EHH 19 ( Fig. 3a,b and Supplementary Fig. 3 ). These could be further supported by data from the HapMap Project (release 22) and the 1000 Genomes Project (pilot 1; see URLs); that is, eight common SNPs (minor allele frequency (MAF) = 0.23-0.24 in the Japanese population) appeared to identify a common haplotype (H5), which arose on a haplotype (H4) that is common in east Asians but is absent in Europeans and is rare in Africans (Supplementary Fig. 4 ), spanning almost the same interval length (0.7 Mb) as that of a suggestive selective sweep. Moreover, in the haplotype analysis involving five (of eight) SNPs genotyped at 12q24.13, rs671 and rs11066132 (r 2 = 0.99 between the two SNPs) clearly differentiated a group of bloodpressure-increasing haplotypes (H1 to H3) from that of blood-pressure-decreasing haplotypes (H4 to H6; Supplementary Fig. 5 ).
These SNPs showed substantial pleiotropic effects on risk factors for cardiovascular disease 17 as well as on susceptibility to coronary artery disease (CAD) in the Japanese population (F. Takeuchi et al., unpublished data), with the strongest association detected at rs671 for several traits besides blood pressure in the Japanese population studied ( Fig. 3c and Supplementary Table 4) . Two additional observations are of note. First, the alleles associated with increased blood pressure were associated with relatively small elevations in fasting glucose and body mass index (BMI), which would be expected to result in elevated risk of CAD. However, the effects of rs671 on lowdensity lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol were larger than those on blood pressure, glucose and BMI and in a direction that would be expected to decrease CAD risk. Indeed, overall, rs671 was associated with reduced risk of CAD (OR = 0.59 for the G allele versus the A allele (95% CI 0.52-0.66), P = 7.7 × 10 −18 ; Supplementary Table 4) . A previous European GWAS 20 reported significant evidence supporting CAD association of a haplotype involving rs3184504 (at SH2B3) identical to that for blood pressure association as well as signatures of natural selection in an overlapping region on 12q24.13. By inspecting the phylogeny of haplotypes in the relevant region, we confirmed that these haplotypes arose independently and that each of the haplotypes was responsible for independent association signals in the two populations ( Supplementary Fig. 4) . Second, given the biological role of ALDH2 in the propensity for alcohol consumption, we further examined to what extent alcohol intake could mediate the effects of rs671 on various cardiovascular risk factors. We showed that most of the associations between rs671 and each of the cardiovascular risk factors were substantially attenuated after adjustment for alcohol intake ( Fig. 3d and Supplementary Table 4 ).
Associations at loci previously identified in Europeans
We also sought to replicate the genome-wide significant and suggestive associations previously identified in populations . In each panel, the lead SNP is represented by a diamond, with stage 1 meta-analysis results denoted by a red diamond and the joint analysis (combined P) results denoted by a blue diamond. The correlation of the lead SNP to other SNPs at the locus is shown on a scale from minimal (white) to maximal (red). Superimposed on the plot are gene locations (green) and recombination rates (light blue). The regional plots were drawn using the SNAP software 35 . At 12q24.13, rs671 was not included in the construction of the regional association plots (e) because the genotype data for this SNP were unavailable from two GWAS in stage 1, KARE and Suita (1), which resulted in an effective sample size of 9,828.
A r t i c l e s of European descent 9, 10 in the AGEN-BP samples (Fig. 4 and Supplementary Table 5 ). We genotyped variants at seven loci (CASZ1, MTHFR, ITGA9, FGF5, CNNM2-NT5C2, ATP2B1 and CSK-ULK3) in the CAGE-Amagasaki, CAGE-Fukuoka and CAGE-KING samples and at two loci (CACNB2 and PLEKHA7) in the CAGE-Amagasaki samples as part of the previous replication study 13 . In the present study, we additionally genotyped in the CAGE-Amagasaki samples three (in C10orf107, PLCD3 and ZNF652) of seven variants that showed directionally consistent and nominally significant blood pressure associations in the stage 1 study; the remaining four (of seven) variants overlapped with those previously genotyped in the CAGE study samples (Supplementary Table 2 ). When these data were combined with our stage 1 data, six of the seven previously replicated loci 13 and one additional locus (ZNF652) still showed directionally consistent associations with blood pressure with P values < 0.05.
In the six variants in which we did not detect blood pressure associations in the east Asian populations (Supplementary Fig. 6) , we compared the effects in our study to those in the follow-up panels in Europeans (to exclude the possible winner's curse effect 21 ). We detected cross-population heterogeneity in effect size for C10orf107 and PLEKHA7 (Supplementary Table 5) . One possibility for our failure to detect an association between these six variants and blood pressure in our population is lack of power. To replicate blood pressure associations previously identified in populations of European descent with P values < 0.05 in east Asians, sample sizes were not sufficient for three (of the six) variants (CACNB2, C10orf107 and TBX3-TBX5; Supplementary Table 6 ). Another possibility could relate to differences in LD patterns between the ethnic groups. We examined LD differences between Europeans (HapMap CEU) and east Asians (HapMap JPT+CHB) at these loci by using the varLD program 22 (Supplementary Fig. 7 ). For the seven reported variants that showed an association with blood pressure in east Asians, there was limited evidence of LD differences between European and east Asian populations at five (of seven) loci that harbor these variants. On the other hand, for the six reported variants for which we did not detect an association with blood pressure in east Asians, we found significant differences in LD between the ethnic groups at four (of six) loci harboring these variants (CACNB2, C10orf107, PLEKHA7 and TBX3-TBX5).
Cumulative impact of risk alleles and association with hypertension
In total, ten variants showed associations that reached genome-wide significance after all stages of our study. These ten variants had a cumulative impact on SBP and DBP (Supplementary Note and Supplementary Fig. 8 ) and were also associated with risk of hypertension (as a dichotomous trait) in directions consistent with the continuous trait effect (Supplementary Note, Supplementary Fig. 9 and Supplementary Tables 7 and 8 ).
eQTL analysis
In search of putative functional variation at the newly identified loci, we found that, among the six genes on 1p13.2, expression of ST7L was associated with expression-associated SNP (eSNP) rs17030613 (P = 9.4 × 10 −15 and P = 1.4 × 10 −8 , reported in two independent studies) 23, 24 in lymphoblastoid cell lines (LCLs) derived from samples of European and east Asian ancestry (Supplementary Fig. 10 ). In the current study, the rs17030613 A allele associated with lower ST7L transcript levels was also associated with lower blood pressure. We identified no other eSNPs or non-synonymous SNPs in LD with blood-pressure-associated variants in currently available public databases for the five newly discovered association signals. Fig. 4) , XP-EHH is assumed to provide more appropriate signals of selection than iHS 18 at 12q24.13. Vertical axes represent empirical P values, where a suggestive level for positive selection is set at P < 0.01 (-log 10 P > 2). The results are shown for all east Asians combined (green line) and for Japanese (black line). (c) The -log 10 P for associations with cardio-metabolic traits at five of the eight SNPs forming a common eastAsian-specific haplotype. The position of each SNP is denoted at the top of the plot. (d) Per-allele effects of rs671 (G versus A) on cardio-metabolic traits with and without adjustment (adj.) for alcohol intake.
DISCUSSION
A r t i c l e s
association signals with genome-wide significance. These include 1p13.2 in ST7L-CAPZA1 (P = 1.2 × 10 −8 for DBP), 2q24.3 in FIGN-GRB14 (P = 3.5 × 10 −11 for SBP), 4q25 in ENPEP (P = 9.0 × 10 −9 for DBP) and 5p13.3 near NPR3 (P = 1.9 × 10 −8 for SBP). At 12q24.21 near TBX3 (a known blood-pressure-associated locus in populations of European descent), we also identified a new blood-pressureassociated variant, illustrating the possible presence of allelic heterogeneity at this locus in relation to blood pressure regulation.
The glutamyl aminopeptidase encoded by ENPEP plays a pivotal role in blood pressure regulation by facilitating conversion of angiotensin II, the main effector protein of the renin-angiotensinaldosterone system, to angiotensin III, and the Enpep knockout mouse develops hypertension 25 . The natriuretic peptide receptor C/ guanylate cyclase C encoded by NPR3 is one of three receptor subtypes that mediate specific binding of the natriuretic peptides, which are important in maintaining blood pressure and extracellular fluid volume 12 . At 2q24.3, the lead SNP (rs16849225) is located between FIGN and GRB14. FIGN encodes fidgetin, a member of a family of ATPases associated with diverse cellular activities 26 . GRB14 encodes the growth factor receptor-bound protein 14 that interacts with insulin receptors and insulin-like growth factor receptors, suggesting a role for GRB14 in signaling pathways that regulate growth and metabolism 27 . A variant close to the GRB14 locus (rs10195252) has been associated with waist-to-hip ratio (WHR) in populations of European descent 28 . The variant we identified for the blood pressure association in this study (rs16849225) is >600 kb from that identified for the WHR association, with the two SNPs being in linkage equilibrium. Although the newly discovered variant at 1p13.2 is in close proximity to six annotated genes, it is an eSNP for ST7L, with consistent results supporting an association between rs17030613 and ST7L transcript levels in the LCLs being shown in two independent studies 23, 24 in three ethnic groups (HapMap CEU, YRI and JPT+CHB; P > 0.05 for testing inter-population per-allele effect difference 23 ). ST7L (suppression of tumorigenicity 7 like) has been identified by its similarity to the ST7 tumor suppressor gene found in the 7q31 region known to be deleted and rearranged in a variety of cancers 29 , although the function of this gene remains to be determined.
Our study provides important information on the genetic architecture of blood pressure variation and CAD in relation to known loci. In this study, we provided evidence suggesting that the association between variants at 12q24.13 and blood pressure is likely related to a non-synonymous SNP (rs671, p.Glu504Lys) in ALDH2. Furthermore, the associations seem to be largely mediated by alcohol intake, a finding that is supported by previous studies showing that this variant determines an individual's tolerance of alcohol intake by altering ALDH2 enzymatic activity 30, 31 . Variants at this locus also appear to have undergone natural selection; phylogenetic analysis suggests that rs671 is not responsible for the blood pressure association identified in the overlapping chromosomal region (near SH2B3) in populations of European descent 9, 10 . Thus, the associations described in our study appear to be specific to east Asians. Moreover, our study highlights the importance of extending studies examining associations with surrogate markers of cardiovascular risk factors (such as blood pressure) to include clinically relevant events (such as CAD) when trying to identify therapeutic targets, especially if the variant of interest could have pleiotropic effects. In this instance, the allele (of rs671) associated with elevated blood pressure was associated with reduced risk of CAD, a finding that is counterintuitive based on what is known about the relationship between blood pressure and CAD. Further analysis suggests that the deleterious effect of the variant on Figure 4 Plots of effect size (β) versus riskallele frequency of 13 loci previously identified in GWAS meta-analysis of blood pressure in individuals of European descent. The list of 13 loci includes one locus (CASZ1) that did not reach genome-wide significance in Europeans but was found to show a significant association with blood pressure in the present AGEN-BP meta-analysis. Plots for SBP (east Asians (a) and Europeans (b)) and DBP (east Asians (c) and Europeans (d)) are depicted separately. Each point refers to a single blood pressure association signal, with colors denoting the strength of the blood pressure association (red, P < 5 × 10 −8 ; orange, 5 × 10 −8 ≤ P < 10 −5 ; green, 10 −5 ≤ P < 0.05; blue, P ≥ 0.05) and with sizes being proportional to the tested sample size. Whiskers are ± standard errors. The gene names associated with each signal have been chosen on the basis of proximity to the lead SNP and should not be presumed to indicate causality. The gray curves represent the coefficient of determination (R 2 ) (blood pressure variance explained by a SNP (%)); those from the top to the bottom correspond to R 2 = 0.1, R 2 = 0.05 and R 2 = 0.02. For estimating R 2 , the standard deviations of blood pressure were assumed to be 19.4 mm Hg (SBP) and 11.0 mm Hg (DBP) in east Asians and 16.6 mm Hg (SBP) and 10.9 mm Hg (DBP) in Europeans 9 . The risk alleles were designated as previously reported in European GWAS meta-analysis. For details, see supplementary table 5. A r t i c l e s blood pressure was balanced by protective effects on HDL cholesterol and LDL cholesterol, resulting in a net reduction in CAD risk. This is reminiscent of the effects of the CETP inhibitor torcetrapib, which increased HDL cholesterol and decreased LDL cholesterol. Despite these cardioprotective effects, its use was associated with increased risk of CAD and mortality, which may relate to an off-target effect causing blood pressure elevation 32 . Second, on examining blood pressure associations for 13 variants identified in GWAS metaanalyses in individuals of European descent (Supplementary Table 5 ), we found that 7 of the 13 loci (54%) showed nominally significant associations of the reported lead SNPs in east Asians. This is consistent with previous studies showing that findings from populations of European ancestry may be relevant to other ethnic groups 13, 33, 34 . We also found another locus (TBX3-TBX5) that showed some evidence of allelic heterogeneity in relation to blood pressure. These data suggest that, although some inter-population differences may exist in the pathways involved in the blood pressure elevation (or hypertension) between Europeans and east Asians, the majority of pathways are common.
A number of factors could have influenced our ability to detect associations at the remaining six loci in the east Asian populations. First, the sample size for genome-wide exploration (stage 1) was smaller in AGEN-BP (n = 19,608) than in two previous consortia of populations of European descent, the Global BPgen (n = 34,433) and CHARGE (n = 29,136) 9,10 , resulting in limited power to detect several of these loci, even using a P value threshold of <0.05 (Supplementary Table 6 ). This limited power also means that additional loci could be identified by enlarging the sample size in the discovery stage, providing motivation for larger meta-analyses in the future. Second, we found some evidence of LD differences between European and east Asian populations at two of seven loci (29%) for which we did detect an association in our study, versus at four of six loci (67%) for which we did not detect an association (Supplementary Fig. 7 ). This could also contribute to our failure to detect associations for some of the known variants in the present study.
In conclusion, although variants identified in European populations are often relevant to other ethnic groups, by conducting a largescale GWAS meta-analysis in east Asians, we identified previously unreported association signals for blood pressure (at ST7L-CAPZA1, FIGN-GRB14, ENPEP and NPR3) that reached genome-wide significance. Near TBX3, we also identified some evidence for allelic heterogeneity in east Asians compared to Europeans in relation to blood pressure associations. Further, our data have provided evidence of east-Asian-specific blood pressure association at ALDH2, which has pleiotropic effects on other metabolic traits and CAD, highlighting the importance of fine-mapping efforts to pinpoint causal variants and causal genes, thereby providing new insights into the physiology of complex diseases.
URLs. HapMap, http://www.hapmap.org/; 1000 Genomes Project, http://www.1000genomes.org/; METAL, http://www.sph.umich.edu/ csg/abecasis/Metal; R, http://www.r-project.org/; GTEx (GenotypeTissue Expression) eQTL Browser, http://www.ncbi.nlm.nih.gov/ gtex/test/GTEX2/gtex.cgi; eQTL.Chicago.edu, http://eqtl.uchicago. edu/cgi-bin/gbrowse/eqtl/; Gene Expression Analysis Based on Imputed Genotypes, http://www.sph.umich.edu/csg/liang/imputation/; SNPExpress, http://people.genome.duke.edu/~dg48/SNPExpress/.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website.
ONLINE METhODS
Stage 1 samples. The Asian Genetic Epidemiology Network (AGEN) is a consortium of genetic epidemiology studies of cardiovascular disease-related phenotypes, such as blood pressure (or hypertension), diabetes and obesity, conducted among Asian populations. AGEN-BP consists of 19,608 east Asian participants who underwent standardized collection of blood pressure measurements in eight population-and family-based GWAS including the Cardiometabolic Genome Epidemiology (CAGE) Network, Genetic Epidemiology Network of Salt-Sensitivity (GenSalt), Korean Association Resource (KARE) Project, Shanghai Hypertension Study, Singapore Malay Eye Survey (SiMES), Singapore Prospective Study (SP2) Program, Suita Study and Taiwan Super Control Study. Each study established a consensus on phenotype harmonization and analytical plan for the within-study GWAS and meta-analysis of results across studies. Each study received approval from the institutional review boards of local research institutions, and all participants in each study provided written informed consent for participation in the study. A detailed description of the study design and phenotype measurement for each study (or cohort) is provided in the Supplementary Note and in Supplementary  Table 1 . The overall design of the three-staged GWAS meta-analysis is depicted in Supplementary Figure 1 . Stage 1 was a meta-analysis of directly genotyped and imputed SNPs from individuals of east Asian descent drawn from population-based or control samples in case-control studies in AGEN-BP.
Genome-wide genotyping and quality control. Genotyping arrays and quality control filters applied to the individual studies are provided in Supplementary Table 1.
Genotype imputation. Imputation of genotypes to the HapMap Phase 2 (JPT+CHB except for SiMES, which used HapMap JPT+CHB+CEU+YRI) set was carried out using MACH 37 , IMPUTE 38 or BEAGLE 39 with preimputation filters as specified in Supplementary Table 1 . Imputation results are summarized as an 'allele dosage' defined as the expected number of copies of the coded allele at that SNP (a fractional value between 0 and 2) for each genotype. In total, up to 2.4 million genotyped or imputed autosomal SNPs were analyzed.
Phenotype modeling and SNP association analysis. For participants taking antihypertensive therapies, blood pressure was imputed by adding 10 mm Hg and 5 mm Hg to SBP and DBP values, respectively 40 . Within each study, continuous SBP and DBP were adjusted for age, age squared, sex, BMI and any study-specific covariates in linear regression models.
In secondary and confirmatory analyses of hypertension, hypertensive cases were defined as follows: (i) SBP ≥ 160 mm Hg and/or DBP ≥ 100 mm Hg for untreated subjects; (ii) individuals receiving chronic antihypertensive treatments; and (iii) age of onset ≤ 65 years. Normotensive controls were defined as follows: (i) SBP < 130 mm Hg and DBP < 85 mm Hg without antihypertensive treatments and (ii) age ≥ 50 years. Within each study, a dichotomous trait of hypertension status was adjusted for age, age squared, sex and BMI in logistic regression models, except for the CAGE samples used for the follow-up and replication (3,294 cases and 6,831 controls; Supplementary Table 7), in which age was not adjusted for because of its relation to case-control status (the mean age was younger in cases than in controls).
Stage 1 meta-analysis. All study-specific effect estimates and coded alleles were oriented to the forward strand of the NCBI36 reference sequence of the human genome. If a SNP from a study did not meet quality standards, it was reported as missing from that study for the purpose of meta-analysis. Results for this SNP were pooled among the other contributing studies. SNPs were excluded if they had study-specific imputation quality R 2 < 0.5. Genomic control 41 was carried out on study-specific test statistics: genomic control lambda (λ GC ) estimates are given in Supplementary Table 1 . We used an inverse-variance-weighted meta-analysis to combine association results for stage 1 with METAL software (see URLs). Evidence for the heterogeneity of the effect sizes was investigated using Cochran's Q statistic 42 . We retained 1.7 million SNPs with MAF > 0.05 and an effective sample size of >10,000. In Figure 1 , we show the Manhattan plots drawn using the WGAViewer software 43 .
SNP prioritization for stage 2. We selected 13 SNPs for follow up in stage 2 using two methods in parallel. Using the first method, the most strongly associated SNP was chosen from each of 12 distinct regions containing ≥1 SNP with P < 1 × 10 −5 for SBP and/or DBP based on the stage 1 data, in which samples from ≥7 (of 8) GWAS were available for the meta-analysis, in principle, to decrease the potential noise of false positive associations caused by the small sample size. We excluded SNPs within 50 kb of the lead SNPs for blood pressure associations previously identified in Europeans 9,10 at CNNM2-NT5C2, ATP2B1 and CSK-ULK3. Although attaining a significance level of P < 1 × 10 −5 for SBP, we did not subject two SNPs (rs4671977 and rs12547784) to follow up in stage 2 because their association with the DBP trait was not significant (P > 0.05) in stage 1. Using the second method, we generated a list of the next most significant SNPs (21 unique loci showed P ≤ 1 × 10 −3 for both SBP and DBP and consistent association signals across the studies). We selected a SNP at 5p13.3 ad hoc because of the physiological candidacy of the nearby gene (NPR3) 12 .
Stage 2 samples and genotyping. We genotyped 13 SNPs in 10,518 individuals of Japanese descent from three studies (CAGE-Amagasaki Study, Suita (2) Study and Ehime Study). Summary characteristics are shown in Table 1 . Study information and genotyping methods are provided in the Supplementary Note. Stage 3 samples, genotyping and joint analysis. For SNP selection in the stage 3 study, we set a threshold of P < 5 × 10 −6 for joint analysis of stages 1 and 2. Six of 13 SNPs exceeded this significance level and were followed up in 20,247 individuals of east Asian descent from three studies by de novo genotyping (for Fukuoka Study and Kita-Nagoya Genomic Epidemiology (KING) Study of the CAGE Network) and in silico replication (for HEXA-shared control).
We carried out meta-analysis of stages 1, 2 and 3 results and considered associations genome-wide significant if they attained P < 5 × 10 −8 . Association results for multiple stages (1 and 2 or 1, 2 and 3) were combined using inverse variance weighting with the rmeta package of the R software (see URLs).
Replication of previously reported loci. Along with genome-wide exploration of new loci, we examined blood pressure associations at 27 loci reported by the European GWAS meta-analyses 9,10 : 13 genome-wide significant loci and 14 loci with suggestive association (Supplementary Table 5) . A one-tailed P < 0.05 (two-tailed P < 0.1) was considered statistically significant for the 13 loci previously shown to have genome-wide significant (P < 5 × 10 −8 ) associations in Europeans; for an association to be considered significant, it had to involve the same risk allele as that reported in Europeans and was accordingly assessed with the one-tailed test. However, two-tailed P values are presented throughout the text for readability. For the 14 loci with suggestive association in the original European studies 9,10 , a one-tailed P < 0.05/14 = 0.0036 was considered statistically significant after Bonferroni correction.
Haplotype phylogeny and positive selection at 12q24.13. Previous studies in populations of European descent claimed significant evidence supporting blood pressure associations 9, 10 and signatures of natural selection 20 in a 1.6-Mb interval at 12q24.13, near which the present study in east Asians also identified strong blood pressure associations. To clarify phylogenic differences in susceptibility variants between the two populations, we inferred the haplotypes and constructed their phylogeny across three HapMap panels (JPT, CEU and YRI) in the 12q24.13 region of interest. Further, using haplotype-based tests, iHS 18 and XP-EHH 19 , we tested the hypothesis that a long-range, evolutionarily derived haplotype, upon which blood-pressure-decreasing alleles could lie, arose from a positive selection in east Asians independently of Europeans.
Pleiotropic effects on cardio-metabolic traits. We tested SNP-trait associations of five SNPs located in the target interval at 12q24.13 for risk factors of cardiovascular disease and CAD. The associations with SBP and DBP, BMI, fasting plasma glucose and lipids were analyzed in the CAGE-Amagasaki Study (for five SNPs) and CAGE-Fukuoka Study (for rs11066280 and rs671 alone) samples with and without adjustment for alcohol intake, where the amount of alcohol consumed was denoted in terms of servings of sake (1 gou (180 ml), the traditional Japanese unit for cup size) of Japanese rice wine is considered equal to 22 g of ethanol) 17 . The association with CAD was analyzed in the CAD case-control panel (1,347 CAD cases and 1,337 controls) derived from the CAGE Network (F . Takeuchi et al., unpublished) . eQTL analysis. Using publicly available data (see URLs), we examined the cis associations (defined as genes within 1 Mb) between each of the five newly discovered blood pressure SNPs and expression of nearby genes in a variety of cells/tissues, for example, LCLs, monocytes, fibroblasts, liver and brain tissues. After initial screening, we narrowed the targets of eQTLs down to LCLs in two databases 23, 24 . Briefly, LCLs, derived from peripheral blood lymphocytes, were available for 209 HapMap samples (comprising 60 CEU, 60 YRI and 89 JPT+CHB individuals) 23 and 378 individuals of European descent 24 . The expression of 47,294 (for 209 HapMap samples) and 54,675 (for 378 Europeans) transcripts was assessed for each individual, whose genotypes were also imputed using the corresponding HapMap dataset. SNPs were tested for cis associations, assuming an additive genetic model, adjusting for non-genetic effects in the gene expression value.
